$111.44
-0.22-0.20%
Pre-Market: Jul 19, 7:59 PM EDT
15 minutes delayed
Comments
Loading...
DexCom
DXCMNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
DexCom (NASDAQ:DXCM) Stock, Analyst Ratings, Price Targets, Forecasts
DexCom Inc has a consensus price target of $208.44 based on the ratings of 28 analysts. The high is $580 issued by Guggenheim on January 7, 2022. The low is $91 issued by Morgan Stanley on June 15, 2022. The 3 most-recent analyst ratings were released by Morgan Stanley, Stifel, and Redburn Atlantic on July 15, 2024, July 12, 2024, and May 30, 2024, respectively. With an average price target of $127.33 between Morgan Stanley, Stifel, and Redburn Atlantic, there's an implied 14.26% upside for DexCom Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Stifel
Redburn Atlantic
Raymond James
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for DexCom
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/15/2024 | Buy Now | 7.68% | Morgan Stanley | Patrick Wood | $132 → $120 | Maintains | Equal-Weight | Get Alert |
| 07/12/2024 | Buy Now | 18.45% | Stifel | Mathew Blackman | $145 → $132 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | 16.65% | Redburn Atlantic | Issie Kirby | → $130 | Initiates | → Neutral | Get Alert |
| 04/26/2024 | Buy Now | 43.58% | Raymond James | Jayson Bedford | $151 → $160 | Maintains | Strong Buy | Get Alert |
| 04/26/2024 | Buy Now | 30.11% | Canaccord Genuity | William Plovanic | $144 → $145 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 46.27% | UBS | Danielle Antalffy | $153 → $163 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | 44.47% | Citigroup | Joanne Wuensch | $148 → $161 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | 48.06% | RBC Capital | Shagun Singh | → $165 | Initiates | → Outperform | Get Alert |
| 01/23/2024 | Buy Now | 35.5% | Raymond James | Jayson Bedford | $147 → $151 | Maintains | Strong Buy | Get Alert |
| 01/03/2024 | Buy Now | 31.91% | Raymond James | Jayson Bedford | $131 → $147 | Maintains | Strong Buy | Get Alert |
| 12/19/2023 | Buy Now | 34.6% | Piper Sandler | Matt O'Brien | $135 → $150 | Maintains | Overweight | Get Alert |
| 12/13/2023 | Buy Now | 22.04% | Wells Fargo | Larry Biegelsen | $110 → $136 | Maintains | Overweight | Get Alert |
| 12/04/2023 | Buy Now | 9.48% | Morgan Stanley | Patrick Wood | $101 → $122 | Maintains | Equal-Weight | Get Alert |
| 10/27/2023 | Buy Now | -9.37% | Morgan Stanley | Patrick Wood | $98 → $101 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | Buy Now | -10.27% | JP Morgan | Michael Weinstein | $160 → $100 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | -1.29% | Leerink Partners | Mike Kratky | → $110 | Initiates | → Outperform | Get Alert |
| 10/10/2023 | Buy Now | 30.11% | Stifel | Mathew Blackman | $155 → $145 | Maintains | Buy | Get Alert |
| 09/29/2023 | Buy Now | -12.06% | Morgan Stanley | Patrick Wood | $131 → $98 | Maintains | Equal-Weight | Get Alert |
| 09/15/2023 | Buy Now | 17.55% | Raymond James | Jayson Bedford | $154 → $131 | Maintains | Strong Buy | Get Alert |
| 09/06/2023 | Buy Now | 23.83% | UBS | Danielle Antalffy | $175 → $138 | Maintains | Buy | Get Alert |
| 08/21/2023 | Buy Now | 16.65% | Baird | Jeff Johnson | $153 → $130 | Maintains | Outperform | Get Alert |
| 07/31/2023 | Buy Now | 23.83% | Barclays | Matt Miksic | $115 → $138 | Maintains | Equal-Weight | Get Alert |
| 07/28/2023 | Buy Now | 43.58% | Piper Sandler | Matt O'Brien | $150 → $160 | Maintains | Overweight | Get Alert |
| 07/28/2023 | Buy Now | 34.6% | Canaccord Genuity | Kyle Rose | $135 → $150 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | 38.19% | Raymond James | Jayson Bedford | $140 → $154 | Maintains | Strong Buy | Get Alert |
| 07/28/2023 | Buy Now | 37.29% | Baird | Jeff Johnson | $145 → $153 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | 34.6% | Citigroup | Joanne Wuensch | $146 → $150 | Maintains | Buy | Get Alert |
| 06/26/2023 | Buy Now | 34.6% | BTIG | Marie Thibault | $134 → $150 | Maintains | Buy | Get Alert |
| 05/30/2023 | Buy Now | 17.55% | Morgan Stanley | Patrick Wood | → $131 | Assumes | → Equal-Weight | Get Alert |
| 05/01/2023 | Buy Now | 3.19% | Barclays | Matt Miksic | $110 → $115 | Maintains | Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | 25.63% | Stifel | Mathew Blackman | $130 → $140 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 20.24% | BTIG | Marie Thibault | $132 → $134 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 21.14% | Canaccord Genuity | Kyle Rose | $125 → $135 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 25.63% | Raymond James | Jayson Bedford | $138 → $140 | Maintains | Strong Buy | Get Alert |
| 04/17/2023 | Buy Now | 18.45% | BTIG | Marie Thibault | $126 → $132 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 23.83% | Raymond James | Jayson Bedford | $127 → $138 | Upgrade | Outperform → Strong Buy | Get Alert |
| 03/29/2023 | Buy Now | 27.42% | UBS | Danielle Antalffy | → $142 | Initiates | → Buy | Get Alert |
| 02/13/2023 | Buy Now | -1.29% | Barclays | Matt Miksic | $103 → $110 | Maintains | Equal-Weight | Get Alert |
| 02/10/2023 | Buy Now | 12.17% | Cowen & Co. | Joshua Jennings | $114 → $125 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | 8.58% | Wolfe Research | Mike Polark | → $121 | Initiates | → Outperform | Get Alert |
| 01/06/2023 | Buy Now | 17.55% | Morgan Stanley | Cecilia Furlong | $117 → $131 | Maintains | Equal-Weight | Get Alert |
| 12/12/2022 | Buy Now | 31.01% | Citigroup | Joanne Wuensch | $117 → $146 | Maintains | Buy | Get Alert |
| 10/28/2022 | Buy Now | 4.99% | Morgan Stanley | Cecilia Furlong | $107 → $117 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | 14.86% | Wells Fargo | Larry Biegelsen | $102 → $128 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 12.17% | Raymond James | Jayson Bedford | $101 → $125 | Maintains | Outperform | Get Alert |
| 10/18/2022 | Buy Now | -7.57% | Barclays | Matt Miksic | → $103 | Initiates | → Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | 12.17% | Jefferies | Matthew Taylor | → $125 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | -3.98% | Morgan Stanley | Cecilia Furlong | $83 → $107 | Maintains | Equal-Weight | Get Alert |
| 10/10/2022 | Buy Now | -1.29% | BTIG | Marie Thibault | $92 → $110 | Maintains | Buy | Get Alert |
| 10/07/2022 | Buy Now | 7.68% | Stifel | Mathew Blackman | $112 → $120 | Maintains | Buy | Get Alert |
| 10/07/2022 | Buy Now | 7.68% | Piper Sandler | Matt O'Brien | $110 → $120 | Maintains | Overweight | Get Alert |
| 08/01/2022 | Buy Now | -9.37% | Raymond James | Jayson Bedford | $122 → $101 | Maintains | Outperform | Get Alert |
| 07/29/2022 | Buy Now | -25.52% | Morgan Stanley | Cecilia Furlong | $91 → $83 | Maintains | Equal-Weight | Get Alert |
| 07/29/2022 | Buy Now | -1.29% | Piper Sandler | Matt O'Brien | $120 → $110 | Maintains | Overweight | Get Alert |
| 07/15/2022 | Buy Now | -5.78% | Bernstein | Lee Hambright | → $105 | Initiates | → Outperform | Get Alert |
| 06/24/2022 | Buy Now | -5.78% | BTIG | Marie Thibault | $135 → $105 | Maintains | Buy | Get Alert |
| 06/15/2022 | Buy Now | -18.34% | Morgan Stanley | David Lewis | $90.75 → $91 | Maintains | Equal-Weight | Get Alert |
| 06/13/2022 | Buy Now | -18.57% | Morgan Stanley | David Lewis | $363 → $90.75 | Maintains | Equal-Weight | Get Alert |
| 06/07/2022 | Buy Now | 225.74% | Morgan Stanley | David Lewis | $123 → $90.75 | Maintains | Equal-Weight | Get Alert |
| 05/17/2022 | Buy Now | 371.11% | Citigroup | Joanne Wuensch | $157.5 → $131.25 | Maintains | Buy | Get Alert |
| 04/29/2022 | Buy Now | 336.11% | Raymond James | Jayson Bedford | $134.5 → $121.5 | Maintains | Outperform | Get Alert |
| 04/29/2022 | Buy Now | 341.49% | Morgan Stanley | David Lewis | $128.5 → $123 | Maintains | Equal-Weight | Get Alert |
| 04/29/2022 | Buy Now | 330.73% | Piper Sandler | Matt O'Brien | $181.25 → $120 | Maintains | Overweight | Get Alert |
| 04/29/2022 | Buy Now | 348.67% | SVB Leerink | Danielle Antalffy | $141.25 → $125 | Maintains | Outperform | Get Alert |
| 02/11/2022 | Buy Now | 361.23% | Morgan Stanley | Cecilia Furlong | $142.5 → $128.5 | Maintains | Equal-Weight | Get Alert |
| 02/03/2022 | Buy Now | 380.08% | BTIG | Marie Thibault | → $133.75 | Upgrade | Neutral → Buy | Get Alert |
| 01/19/2022 | Buy Now | 415.97% | Wells Fargo | Lawrence Biegelsen | → $143.75 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/19/2022 | Buy Now | 382.77% | Raymond James | Jayson Bedford | $154.5 → $134.5 | Maintains | Outperform | Get Alert |
| 01/07/2022 | Buy Now | 411.49% | Morgan Stanley | Cecilia Furlong | $144 → $142.5 | Maintains | Equal-Weight | Get Alert |
| 01/07/2022 | Buy Now | 420.46% | Guggenheim | Chris Pasquale | → $145 | Upgrade | Neutral → Buy | Get Alert |
| 11/03/2021 | Buy Now | 573.01% | Piper Sandler | Matt O'Brien | — | Maintains | Overweight | Get Alert |
| 11/01/2021 | Buy Now | 454.56% | Raymond James | Jayson Bedford | — | Maintains | Outperform | Get Alert |
| 10/29/2021 | Buy Now | 416.87% | Morgan Stanley | Cecilia Furlong | — | Maintains | Equal-Weight | Get Alert |
| 10/29/2021 | Buy Now | 541.6% | SVB Leerink | Danielle Antalffy | — | Maintains | Outperform | Get Alert |
| 10/18/2021 | Buy Now | — | Guggenheim | Christopher Pasquale | — | Downgrade | Buy → Neutral | Get Alert |
| 09/16/2021 | Buy Now | 483.27% | Piper Sandler | Matt O'Brien | — | Maintains | Overweight | Get Alert |
| 08/02/2021 | Buy Now | 357.65% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
| 07/30/2021 | Buy Now | 393.54% | Piper Sandler | Matt O'Brien | — | Maintains | Overweight | Get Alert |
| 07/30/2021 | Buy Now | 348.67% | Canaccord Genuity | Kyle Rose | — | Maintains | Buy | Get Alert |
| 07/30/2021 | Buy Now | 371.11% | Oppenheimer | Steven Lichtman | — | Maintains | Outperform | Get Alert |
| 07/30/2021 | Buy Now | 362.13% | Raymond James | Jayson Bedford | — | Maintains | Outperform | Get Alert |
| 07/30/2021 | Buy Now | 326.24% | Wells Fargo | Larry Biegelsen | — | Maintains | Equal-Weight | Get Alert |
| 07/30/2021 | Buy Now | 348.67% | SVB Leerink | Danielle Antalffy | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for DexCom (DXCM) stock?
The latest price target for DexCom (NASDAQ:DXCM) was reported by Morgan Stanley on July 15, 2024. The analyst firm set a price target for $120.00 expecting DXCM to rise to within 12 months (a possible 7.68% upside). 26 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DexCom (DXCM)?
The latest analyst rating for DexCom (NASDAQ:DXCM) was provided by Morgan Stanley, and DexCom maintained their equal-weight rating.
When was the last upgrade for DexCom (DXCM)?
The last upgrade for DexCom Inc happened on April 17, 2023 when Raymond James raised their price target to $138. Raymond James previously had an outperform for DexCom Inc.
When was the last downgrade for DexCom (DXCM)?
The last downgrade for DexCom Inc happened on October 18, 2021 when Guggenheim changed their price target from N/A to N/A for DexCom Inc.
When is the next analyst rating going to be posted or updated for DexCom (DXCM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DexCom, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DexCom was filed on July 15, 2024 so you should expect the next rating to be made available sometime around July 15, 2025.
Is the Analyst Rating DexCom (DXCM) correct?
While ratings are subjective and will change, the latest DexCom (DXCM) rating was a maintained with a price target of $132.00 to $120.00. The current price DexCom (DXCM) is trading at is $111.44, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.